Home | Privacy | Contact    

Health Information About Hepatocellular Carcinoma


Hepatocellular carcinoma - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Hepatocellular_carcinoma Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer. Most cases of HCC are secondary to either a viral hepatitide ... more...
Hepatocellular carcinoma: MedlinePlus Medical Encyclopedia
http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm Hepatocellular carcinoma is cancer of the liver. Causes Hepatocellular carcinoma accounts for most liver cancers. This type of cancer occurs more often in men than ... more...
Hepatocellular Carcinoma
http://emedicine.medscape.com/article/197319-overview Hepatocellular carcinoma (HCC) is a primary malignancy of the liver. Hepatocellular carcinoma is now the third leading cause of cancer deaths worldwide, with over ... more...
Hepatocellular carcinoma - PubMed Health - National Center for ...
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001325/ Causes, incidence, and risk factors. Hepatocellular carcinoma accounts for most liver cancers. This type of cancer occurs more often in men than women. more...
Hepatic Carcinoma, Primary
http://emedicine.medscape.com/article/282814-overview Hepatocellular carcinoma (HCC) is a primary malignancy of the hepatocyte, generally leading to death within 6-20 months. Hepatocellular carcinoma frequently arises in ... more...



Hepatocellular Carcinoma News


hepatocellular carcinoma - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
Enrollment opens in sorafenib vs. radioembolization in advanced
'SARAH' - a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced read more...
Brain metastases from
Brain metastases (BM) from read more...
Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with
Exelixis, Inc. (NASDAQ:EXEL) today reported positive preliminary data from the cohort of read more...
Phase 2 Study of Cabozantinib for
Exelixis reported positive preliminary data from a cohort of read more...